Preclinical studies, which included in vitro and animal models, explored the molecular mechanisms and the pathophysiological role of TREM2 in PD under controlled experimental conditions, while clinical studies evaluate the translational relevance of these findings in the human population, examining associations with disease progression, biomarker utility, and therapeutic applications. Here, TREM2 is linked to Parkinson disease.